Free shipping on all orders over $ 500

BRD4/CK2-IN-1

Cat. No. M45293

All AbMole products are for research use only, cannot be used for human consumption.

BRD4/CK2-IN-1  Structure

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

BRD4/CK2-IN-1 is a potent, orally active dual-targeted inhibitor of BRD4/CK2 (bromodomain-containing protein 4/casein kinase 2) with IC50 values of 180 nM and 230 nM, respectively.BRD4/CK2-IN-1 exhibits potent anticancer activity without significant toxicity and induces apoptosis and autophagy-related cell death in triple-negative breast cancer (TNBC). autophagy-related cell death in triple negative breast cancer (TNBC).

Chemical Information
Molecular Weight 564.03
Formula C29H30ClN5O5
CAS Number 2756851-99-5
Form Solid
Solubility (25°C) DMSO 20 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Xuesong Li, et al. Acta Pharm Sin B. Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB-P300-BRD4 axis

[2] Beibei Liu, et al. Proc Natl Acad Sci U S A. BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer

[3] Jian Wang, et al. Clin Transl Med. BRD4-IRF1 axis regulates chemoradiotherapy-induced PD-L1 expression and immune evasion in non-small cell lung cancer

[4] Shwu-Yuan Wu, et al. Mol Cell. Opposing Functions of BRD4 Isoforms in Breast Cancer

[5] Benedetta Donati, et al. Mol Cancer. BRD4 and Cancer: going beyond transcriptional regulation

Related Casein Kinase Products
Silmitasertib (CX-4945)

CX-4945 (Silmitasertib) is a potent small molecule protein kinase inhibitor that selectively binds to and inhibits the enzyme casein kinase II (CK2).

PF-4800567

PF-4800567 is a selective, ATP competitive casein kinase 1ε inhibitor with IC50 values of 32 and 711 nM for CK1ε and CK1δ respectively.

D4476

D4476 is a selective inhibitor of casein kinase 1 (CK1) and TGF-β type-I receptor (ALK5) with IC50 of 0.3 µM and 0.5 µM, respectively.

TTP 22

TTP 22 is a high affinity, ATP-competitive casein kinase 2 (CK2) inhibitor with IC50/Ki of 0.1 uM/40 nM.

TBB

TBB(NSC 231634) is a highly selective, ATP/GTP-competitive inhibitor of casein kinase-2 (CK2)with IC50s of 0.9 and 1.6 μM for rat liver and human recombinant CK2 respectively).

  Catalog
Abmole Inhibitor Catalog




Keywords: BRD4/CK2-IN-1 supplier, Casein Kinase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.